drugset / Trial / NCT06566469

Dexmedetomidine-esketamine Combined Nasal Administration and Emergence Delirium

NCT06566469

Phase 4 Completed 340 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Emergence delirium is common in older patients after surgery and associated with worse perioperative outcomes, including increased postoperative delirium. Nasal administrations of both dexmedetomidine and esketamine are approved for medical purposes. Combination of low-dose dexmedetomidine and esketamine has shown some synergic effects in analgesia and anxiolysis. In a recent randomized trial, combined nasal administration of dexmedetomidine and esketamine was more effective in reducing pre-dental anxiety in pediatric patients. The investigators hypothesize that perioperative nasal administration of dexmedetomidine-esketamine combination can reduce the incidence of emergence delirium in older patients after surgery.

Timeline

Start
2024-09-02
Primary completion
2025-03-28
Completion
2025-05-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intranasal
Subject Esketamine Other / unclassified 0.2 mg/kg Intranasal

Indications